The Maria Sklodowska-Curie National Research Institute of Oncology is a specialized research institute and hospital of the Polish Ministry of Health. Based in Warsaw, it also has regional branches in Gliwice and Kraków.

During the past decade, Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie Klinika Nowotworów Piersi i Chirurgii conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 10 clinical trials were completed, i.e. on average, 142.9% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie Klinika Nowotworów Piersi i Chirurgii" #1 collaborator was "Hoffmann-La Roche" with 2 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "SOLTI Breast Cancer Research Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie Klinika Nowotworów Piersi i Chirurgii" are "Breast Cancer" (6 trials), "Metastatic Breast Cancer" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Non-Squamous Non-Small Cell Lung Cancer" (2 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie Klinika Nowotworów Piersi i Chirurgii" in a lesser frequency.

Most popular intervention types in "Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie Klinika Nowotworów Piersi i Chirurgii" are "Drug" (15 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (7 trials), "Placebo" (6 trials), "Atezolizumab" (5 trials), "Paclitaxel" (4 trials) and "Pertuzumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie Klinika Nowotworów Piersi i Chirurgii" are 11 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie Klinika Nowotworów Piersi i Chirurgii". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie Klinika Nowotworów Piersi i Chirurgii, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie Klinika Nowotworów Piersi i Chirurgii, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".